Senate bill aims to soothe helium market


The US Senate has passed a bill that will let the government continue selling off its stockpiled helium, in an attempt to prevent a disruption of supply that could adversely affect researchers around the world. Currently, sales of the American stockpile, mainly built up during the cold war, supply 42% of the US and and 35% of global demand for the gas. 

In 1996, US lawmakers ordered the sale of the federal helium stores to pay off the accumulated debts of $1.3 billion (£840 million) of the US Federal Helium Reserve in Amarillo, Texas. However, the sell off is set to end in October as the facility's debts have been settled. Global production elsewhere is unable to meet current demands and researchers around the world had warned the 'helium cliff' could severely affect global research and development if the US reduces exports of the gas. However, while the sale looks set to continue, the price of helium is expected to rise. The current sell off has supressed the market value for helium and discouraged conservation and exploration for new sources. 

The bill will now move to the the House of Representatives, which passed a similar bill back in April. The Senate and Representatives bills are similar but differ slightly in how the remaining helium will be sold off and what will be done with the proceeds.


Related Content

It's even cheaper being green

30 April 2014 Premium contentFeature

news image

Reducing the environmental impact of your lab can save money as well as water and fuel. Phillip Broadwith reports

Hanging on to helium

21 August 2014 Last Retort

news image

Coping with our dwindling supplies of a gas that disappears into space

Most Read

Sun rises on new solar route to hydrogen

27 February 2015 Research

news image

Photocatalyst has solar-to-hydrogen conversion efficiency of 2% and points way to cheap production of the gas

The mothers of invention

24 February 2015 Managing Change

news image

Nina Notman profiles four researchers successfully balancing an academic career with family life

Most Commented

Sun rises on new solar route to hydrogen

27 February 2015 Research

news image

Photocatalyst has solar-to-hydrogen conversion efficiency of 2% and points way to cheap production of the gas

Hepatitis C drug patent challenged in Europe

19 February 2015 Business

news image

Campaign group says Gilead’s expensive blockbuster sofosbuvir is not innovative enough to warrant a patent